BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1255793)

  • 1. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
    Canevari S; Fossati G; Della Porta G
    J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors.
    de Vries JE; Meyering M; van Dongen A; Rümke P
    Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-mediated cytotoxicity on human tumor cells in vitro.
    Schwenke H; Schönfelder M
    Arch Geschwulstforsch; 1975; 45(8):802-9. PubMed ID: 1241765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human malignant melanoma cells: morphological and immunological variations.
    Hakim AA
    Neoplasma; 1977; 24(1):81-99. PubMed ID: 840339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
    Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
    Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients.
    de Vries JE; Rümke P
    Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
    Steele G; Sjögren HO; Stadenberg I
    Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
    Knuth A; Danowski B; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3511-5. PubMed ID: 6610177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
    Peter HH; Knoop F; Kalden JR
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular microcytotoxicity in human tumor systems: analysis of results.
    Oldham RK; Djeu JY; Cannon GB; Siwarski D; Herberman RB
    J Natl Cancer Inst; 1975 Dec; 55(6):1305-18. PubMed ID: 54436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
    Saal JG; Rieber EP; Riethmüller G
    Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral cytotoxicity in melanoma patients and its correlation with the extent and course of the disease.
    Canevari S; Fossati G; Della Porta G; Balzarini GP
    Int J Cancer; 1975 Nov; 16(5):722-9. PubMed ID: 1184240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte anergy in patients with carcinoma.
    Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES
    Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.